6241 |
8G9W |
HL_E |
vFP49.02 Fab |
HIV-1 BG505 DS-SOSIP.664 envelope glycoprotein - gp120 |
Human immunodeficiency virus 1, Mus musculus |
EM |
4.66 | 10.1128/jvi.01604-22 |
6242 |
8G9X |
HL_O |
vFP49.02 Fab |
HIV-1 BG505 DS-SOSIP.664 envelope glycoprotein - gp41 |
Human immunodeficiency virus 1, Mus musculus |
EM |
4.46 | 10.1128/jvi.01604-22 |
6243 |
8G9Y |
HL_D |
vFP49.02 Fab |
HIV-1 BG505 DS-SOSIP.664 envelope glycoprotein - gp41 |
Human immunodeficiency virus 1, Mus musculus |
EM |
4.28 | 10.1128/jvi.01604-22 |
6244 |
8GAS |
HL_B |
vFP48.02 Fab |
HIV-1 BG505 DS-SOSIP envelope glycoprotein - gp41 |
Mus musculus, Human immunodeficiency virus 1 |
EM |
4.04 | 10.1128/jvi.01604-22 |
6245 |
8GAS |
CA_E |
vFP48.02 Fab |
HIV-1 BG505 DS-SOSIP envelope glycoprotein - gp41 |
Mus musculus, Human immunodeficiency virus 1 |
EM |
4.04 | 10.1128/jvi.01604-22 |
6246 |
8GAS |
IF_K |
vFP48.02 Fab |
HIV-1 BG505 DS-SOSIP envelope glycoprotein - gp41 |
Mus musculus, Human immunodeficiency virus 1 |
EM |
4.04 | 10.1128/jvi.01604-22 |
6247 |
8GF2 |
CD_A |
CC12.3 Fab |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
2.85 | 10.1126/scisignal.abk3516 |
6248 |
8GF2 |
EF_B |
CC12.3 Fab |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
2.85 | 10.1126/scisignal.abk3516 |
6249 |
8GF2 |
HL_A |
eCR3022.20 Fab |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
2.85 | 10.1126/scisignal.abk3516 |
6250 |
8GF2 |
XY_B |
eCR3022.20 Fab |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
2.85 | 10.1126/scisignal.abk3516 |
6251 |
8GH4 |
HL_E |
1H5 Fab |
Bos taurus disintegrin and metalloproteinase domain-containing protein 10 (ADAM10 disentegrin cysteine rich domains) |
Homo sapiens, Bos taurus |
XRD |
3.8 | 10.1016/j.biopha.2023.114494 |
6252 |
8GHP |
HL_A |
anti-GUCY2C Fv |
Human guanylyl cyclase C |
Homo sapiens |
XRD |
3.52 | 10.1038/s41598-023-40467-0 |
6253 |
8GHR |
C_A |
VH27 VHH |
Human ectodomain phosphatase/phosphodiesterase-1 (ENPP1) |
Homo sapiens |
EM |
3.2 | 10.1038/s41589-023-01368-5 |
6254 |
8GHR |
D_B |
VH27 VHH |
Human ectodomain phosphatase/phosphodiesterase-1 (ENPP1) |
Homo sapiens |
EM |
3.2 | 10.1038/s41589-023-01368-5 |
6255 |
8GJE |
HL_A |
3BNC117 Fab |
HIV-1 CZA97.012 SOSIP.664 envelope glycoprotein - gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.4 | 10.1371/journal.ppat.1011601 |
6256 |
8GJE |
GJ_C |
3BNC117 Fab |
HIV-1 CZA97.012 SOSIP.664 envelope glycoprotein - gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.4 | 10.1371/journal.ppat.1011601 |
6257 |
8GJE |
IK_D |
3BNC117 Fab |
HIV-1 CZA97.012 SOSIP.664 envelope glycoprotein - gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.4 | 10.1371/journal.ppat.1011601 |
6258 |
8GJN |
AB_C |
17B10 Fab |
SARS-CoV-2 B.1.3 (G614) spike glycoprotein RBD |
Mus musculus, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.6 | 10.1002/jmv.28673 |
6259 |
8GNG |
HL_A |
KW-6356 Fab |
Human adenosine receptor A2a |
Homo sapiens, Mus musculus |
XRD |
3.2 | 10.1124/molpharm.122.000633 |
6260 |
8GNG |
ZY_X |
KW-6356 Fab |
Human adenosine receptor A2a |
Homo sapiens, Mus musculus |
XRD |
3.2 | 10.1124/molpharm.122.000633 |